FDA Considers Lifting Safety Limits on Avandia

By: Associated Press Email
By: Associated Press Email

WASHINGTON (AP) -- A former blockbuster diabetes pill that is subject to major safety restrictions may not be as dangerous as once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug.

The Food and Drug Administration is reviewing a new interpretation of Avandia's heart attack risk, which suggests that the drug is as safe as older diabetes drugs. At a highly unusual meeting this week, the FDA will ask a panel of experts to vote on a range of options for the drug, including lifting safety restrictions on its use.

The safety review is the latest twist in a years-long debate over Avandia that has divided medical experts. The drug was approved in 1999 and grew into a blockbuster, but regulators restricted its use due to unresolved safety questions in 2010.


Join the Conversation!

To comment, the following rules must be followed:

  • No Obscenity, Profanity, Vulgarity, Racism or Violent Descriptions
  • No Negative Community Comparisons
  • No Fighting, Name-calling, or Personal Attacks
  • Multiple Accounts are Not Allowed
  • Stay on Story Topic

Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.

Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Questions may be sent to comments@wsaw.com.
Please provide detailed information.
All comments must adhere to the WSAW.com discussion rules.

powered by Disqus
WSAW-TV 1114 Grand Ave. Wausau, WI 54403
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 209920671 - wsaw.com/a?a=209920671